Search

Your search keyword '"Diana Cantero"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Diana Cantero" Remove constraint Author: "Diana Cantero"
29 results on '"Diana Cantero"'

Search Results

9. Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab

10. Autosomal dominant distal myopathy with nemaline rods due to p.Glu197Asp mutation in ACTA1

11. Bethlem myopathy: a series of 16 patients and description of seven new associated mutations

12. Immune profiling of gliomas reveals a connection with Tau function and the tumor vasculature

13. Immune profiling of gliomas reveals a connection with Tau function and the tumor vasculature

14. TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors

15. Persistent asymptomatic or mild symptomatic hyperCKemia due to mutations in ANO5: the mildest end of the anoctaminopathies spectrum

16. Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype

17. Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO)

18. Tumor cell vanishing with radiological changes suggesting progression in IDH-mutated diffuse astrocytoma treated only with surgery

19. Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing

20. Milder forms of α-sarcoglicanopathies diagnosed in adulthood by NGS analysis

21. Late onset distal myopathy: A new telethoninopathy

22. Myosin myopathy with external ophthalmoplegia associated with a novel homozygous mutation inMYH2

23. Phase II trial of palbociclib in recurrent RB-positive anaplastic oligodendroglioma: A Spanish group for research in neurooncology (GEINO) trial

24. Study of tumor infiltrating immune CELLS and vasculature in human gliomas: Differences in IDH1/2 mutant versus IDH1/2WT tumors

26. Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma

27. Temozolomide induces radiologic pseudoprogression and tumor cell vanishing in oligodendroglioma

28. Comparison on the calibrations of hydrometers for liquids density determination between SIM laboratories

Catalog

Books, media, physical & digital resources